Stay updated on Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.

Latest updates to the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Cordaleo, Turkey as a study site; removed Karşıyaka, Turkey as a study site.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a detailed description of the two-part study design (dose escalation and expansion) and clarified treatment arms, dosing schedules, and timelines. Updated the study's participating locations and expanded cohort information.SummaryDifference3%

- Check38 days agoChange DetectedAdded a prominent notice about a lapse in government funding, stating that information may not be up to date and inquiries may not be processed; included links to status pages. Revision updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

- Check45 days agoChange DetectedAdded a glossary toggle and new QC/status and policy/version labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older QC label, older policy wording (No FEAR Act data), and the v3.3.4 revision.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded two new fields to the study record: Certification/Extension First Submitted and Certification/Extension Dates, which reflect submission and QC history for the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.